"10.1371_journal.pone.0052028","plos one","2012-12-14T00:00:00Z","Erin Arthurs; Russell J Steele; Marie Hudson; Murray Baron; Brett D Thombs; (CSRG) Canadian Scleroderma Research Group","Department of Psychiatry, McGill University, Montréal, Québec, Canada; Department of Mathematics and Statistics, McGill University, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, Québec, Canada; Department of Medicine (Division of Rheumatology), McGill University, Montréal, Québec, Canada; Department of Educational and Counselling Psychology, McGill University, Montréal, Québec, Canada; School of Nursing, McGill University, Montréal, Québec, Canada; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada","¶ Membership of the Canadian Scleroderma Research Group (CSRG) is provided in the Acknowledgments.","Actelion Pharmaceuticals and Pfizer Inc. have provided unrestricted educational and research funds to the Canadian Scleroderma Research Group. The commercial funding that provides support to the CSRG does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","12","Erin Arthurs","EA",6,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
